Case File №
#VI-2026-0349
Regenerative Research
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
39 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 9.7 | 9.7 | 9.7 | 20 Jun 2025 |
| Tesamorelin | X Unrated | 1 | 3.0 | 3.0 | 3.0 | 29 Jun 2025 |
| AA Water | X N/A | 1 | 8.3 | 8.3 | 8.3 | 14 Jan 2025 |
| ACE-031 | X N/A | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 |
| AICAR Oral | X N/A | 1 | 7.9 | 7.9 | 7.9 | 21 May 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 4.0 | 4.0 | 4.0 | 28 Mar 2025 |
| BMK glycidic acid (free acid) CAS 25547-51-7 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 1 | 4.4 | 4.4 | 4.4 | 6 May 2025 |
| Botulinum toxin | X N/A | 1 | 6.7 | 6.7 | 6.7 | 8 Jul 2025 |
| BPC 500mcg + TB500 500mcg Blend Oral | X N/A | 1 | 4.0 | 2.3 | 2.3 | 13 Jun 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 |
| Chonluten | X N/A | 1 | 5.8 | 5.8 | 5.8 | 3 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.5 | 4.5 | 4.5 | 13 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 6.7 | 6.7 | 6.7 | 2 Apr 2025 |
| Enclomiphene | X N/A | 1 | 4.0 | 3.9 | 3.9 | 17 Dec 2024 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 20 Jun 2025 |
| Flibanserin | X N/A | 1 | 5.4 | 5.4 | 5.4 | 3 Jul 2025 |
| Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | X N/A | 1 | 5.1 | 5.1 | 5.1 | 14 Jan 2025 |
| Hyaluronic acid | X N/A | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 |
| IGF-1 LR3 | X N/A | 1 | 4.0 | 3.9 | 3.9 | 2 Apr 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 |
| Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 24 Apr 2025 |
| MOTS-C | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Feb 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 8.1 | 8.1 | 8.1 | 20 Jun 2025 |
| NA Semax Amidate | X N/A | 1 | 6.9 | 6.9 | 6.9 | 7 May 2025 |
| NAD+ Injectable | X N/A | 1 | 6.4 | 6.4 | 6.4 | 8 Jul 2025 |
| Nandrolone Decanoate (Deca) Raw | X N/A | 1 | 9.0 | 9.0 | 9.0 | 21 May 2025 |
| NPP | X N/A | 1 | 8.0 | 8.0 | 8.0 | 24 Apr 2025 |
| Ovagen | X N/A | 1 | 7.4 | 7.4 | 7.4 | 8 Jul 2025 |
| PEG MGF | X N/A | 1 | 4.9 | 4.9 | 4.9 | 3 Jun 2025 |
| Prostamax | X N/A | 1 | 4.0 | 3.8 | 3.8 | 3 Jun 2025 |
| Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | X N/A | 1 | 6.4 | 6.4 | 6.4 | 24 Apr 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 4.9 | 4.9 | 4.9 | 9 Jun 2025 |
| Romosozumab | X N/A | 1 | 4.0 | 3.4 | 3.4 | 20 Jun 2025 |
| Semax | X N/A | 1 | 5.1 | 5.1 | 5.1 | 2 Jul 2025 |
| SNAP-8 | X N/A | 1 | 4.0 | 3.5 | 3.5 | 11 Jun 2025 |
| Super Shred | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| Vilon | X N/A | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 5.5 B | 100mg/ml | 90.6mg/ml | -9.4% | 98.33% | mlz38c | Lab A | Community |
| 24 May 2026 | MOTS-C | 8.0 A | 10mg | 12.5mg | +24.8% | 96.14% | 7n8m94 | Lab D | Community |
| 24 May 2026 | Relaxation PM (GABA 100mg+Melatonin 1mg+Arginine 100mg+Glutamine 25mg) | 4.4 C | 200mg/ml | 189.9mg/ml | -5.1% | 95.03% | nwlss6 | Lab A | Community |
| 24 May 2026 | Hyaluronic acid | 7.2 A | 2mg | 1.8mg | -8.4% | 97.22% | oxeh0k | Lab A | Community |
| 24 May 2026 | Vilon | 9.6 A | 15mg | 16.5mg | +10.2% | 97.99% | 0kv0ww | Lab D | Public |
| 21 May 2026 | Flibanserin | 5.4 B | 10mg | 9.9mg | -0.9% | 97.22% | rwdxoe | Lab G | Public |
| 21 May 2026 | Healthy Hair Skin Nails Blend (Niacinamide+Thiamine+Pantothenic Acid+Choline+Inositol+Niacin+Biotin+Folic Acid+Riboflavin) | 6.7 A | 100mg/ml | 97.9mg/ml | -2.1% | 98.26% | cfd6i9 | Lab E | Community |
| 21 May 2026 | BPC 500mcg + TB500 500mcg Blend Oral | 4.0 C | 10mg | 9.2mg | -8.1% | 96.06% | g36567 | Lab B | Public |
| 21 May 2026 | Nandrolone Decanoate (Deca) Raw | 7.8 A | 500g | 491.4g | -1.7% | 97.65% | jqrgln | Lab D | Public |
| 20 May 2026 | BMK glycidic acid (free acid) CAS 25547-51-7 | 4.0 C | 500g | 477.0g | -4.6% | 95.65% | c4sq9v | Lab C | Community |
| 20 May 2026 | Romosozumab | 5.0 B | 2mg | 1.9mg | -7.2% | 97.43% | 7jdbfs | Lab F | Public |
| 20 May 2026 | Super Shred | 6.3 A | 200mg/ml | 239.4mg/ml | +19.7% | 95.86% | irfe5u | Lab A | Public |
| 17 May 2026 | BPC157 5mg + TB500 5mg Blend | 8.2 A | 30mg | 35.5mg | +18.3% | 97.44% | io68qx | Lab D | Community |
| 17 May 2026 | Retatrutide 30mg Pen Kit | 4.4 C | 15mg | 17.6mg | +17.5% | 95.80% | 29e7ar | Lab B | Community |
| 29 Jan 2026 | Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) | 6.6 A | 300mg/ml | 289.8mg/ml | -3.4% | 96.66% | en1kpj | Lab E | Public |
| 26 Jan 2026 | Blend 500 (Tren E/Mast E) | 4.0 C | 300mg/ml | 314.9mg/ml | +5.0% | 97.08% | 3141jk | Lab G | Public |
| 26 Jan 2026 | Boldenone Undecylenate (EQ) Raw | 4.6 C | 500g | 522.3g | +4.5% | 96.77% | 8m2eee | Lab G | Public |
| 26 Jan 2026 | NPP | 5.6 B | 200mg/ml | 219.3mg/ml | +9.6% | 98.10% | 6mumxc | Lab E | Public |
| 19 Jan 2026 | CJC-1295 With DAC | 5.3 B | 5mg | 6.1mg | +21.3% | 97.57% | 3zc3l0 | Lab B | Public |
| 19 Jan 2026 | Ovagen | 5.5 B | 15mg | 18.5mg | +23.4% | 99.86% | wrzhv0 | Lab F | Community |
| 9 Jan 2026 | NA Semax Amidate | 6.2 A | 50mg | 55.4mg | +10.9% | 99.98% | db66xl | Lab F | Public |
| 9 Jan 2026 | Semax | 5.3 B | 20mg | 17.9mg | -10.6% | 99.56% | yeajj9 | Lab B | Community |
| 7 Jan 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 4.8 C | 10mg | 10.6mg | +5.9% | 95.76% | 5vpcp1 | Lab B | Community |
| 6 Jan 2026 | AICAR Oral | 10.0 A | 50mg | 51.6mg | +3.1% | 97.20% | gy9g9f | Lab B | Public |
| 6 Jan 2026 | Botulinum toxin | 6.1 A | 15mg | 13.5mg | -10.0% | 96.11% | 38ydd5 | Lab C | Public |
| 29 Dec 2025 | Lipo-C FOCUS 425mg | 5.9 B | 300mg/ml | 373.1mg/ml | +24.4% | 95.19% | lymqnh | Lab B | Public |
| 29 Dec 2025 | NAD+ Injectable | 6.6 A | 300mg/ml | 355.0mg/ml | +18.3% | 99.84% | fsgtxe | Lab E | Public |
| 29 Dec 2025 | Prostamax | 4.0 C | 10mg | 10.7mg | +6.5% | 98.18% | lwg2ob | Lab E | Community |
| 23 Nov 2025 | N-Acetyl Epitalon Amidate | 9.0 A | 10mg | 9.0mg | -10.0% | 97.85% | kek9i9 | Lab G | Public |
| 14 Nov 2025 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 6.1 A | 500g | 466.6g | -6.7% | 98.47% | j9o65l | Lab C | Public |
| 5 Nov 2025 | AA Water | 9.5 A | 5mg | 5.5mg | +10.7% | 99.69% | 7dt0kz | Lab G | Community |
| 9 Oct 2025 | Chonluten | 5.8 B | 5mg | 6.0mg | +19.7% | 96.94% | v6ngxs | Lab C | Public |
| 9 Oct 2025 | Enclomiphene | 4.0 C | 50mg | 45.5mg | -9.0% | 95.32% | fr55yw | Lab A | Public |
| 9 Oct 2025 | IGF-1 LR3 | 4.0 C | 50mg | 52.9mg | +5.8% | 96.14% | z5u9it | Lab B | Community |
| 9 Oct 2025 | PEG MGF | 4.1 C | 5mg | 4.9mg | -1.4% | 99.11% | 4azhni | Lab C | Community |
| 9 Oct 2025 | SNAP-8 | 4.0 C | 50mg | 59.1mg | +18.1% | 95.19% | ji3eou | Lab B | Community |
| 3 Oct 2025 | ACE-031 | 7.8 A | 20mg | 22.1mg | +10.6% | 96.92% | jtljau | Lab G | Public |
| 29 Jun 2025 | Tesamorelin | 3.0 E | 10mg | 3.66mg | -63.4% | 48.94% | TS25-01 | Lab E | Public |
| 20 Jun 2025 | Retatrutide | 9.7 A | 20mg | 19.5mg | -2.5% | 99.78% | RT25-01 | Lab E | Public |
— END OF EVIDENCE LOG —